Revolution Medicines Inc (NASDAQ: RVMD) kicked off on Friday, down -0.36% from the previous trading day, before settling in for the closing price of $41.14. Over the past 52 weeks, RVMD has traded in a range of $26.95-$62.40.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Annual sales at Healthcare sector company slipped by -23.15% over the past five years. While this was happening, its average annual earnings per share was recorded 10.03%. With a float of $154.04 million, this company’s outstanding shares have now reached $167.75 million.
Let’s look at the performance matrix of the company that is accounted for 378 employees. In terms of profitability, gross margin is -17912.67%, operating margin of -88031.94%, and the pretax margin is -76377.09%.
Revolution Medicines Inc (RVMD) Insider and Institutional Ownership
Our next focus will be how large-scale investors are participating in this stock of the Biotechnology Industry. The insider ownership of Revolution Medicines Inc is 15.52%, while institutional ownership is 81.80%. The most recent insider transaction that took place on Jan 21 ’25, was worth 97,443. In this transaction General Counsel of this company sold 2,406 shares at a rate of $40.50, taking the stock ownership to the 39,222 shares. Before that another transaction happened on Jan 21 ’25, when Company’s Officer proposed sale 2,406 for $40.29, making the entire transaction worth $96,938.
Revolution Medicines Inc (RVMD) Latest Financial update
Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.95 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 10.03% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will plunge by -1.63% during the next five years compared to -36.05% drop over the previous five years of trading.
Revolution Medicines Inc (NASDAQ: RVMD) Trading Performance Indicators
Take a look at Revolution Medicines Inc’s (RVMD) current performance indicators. Last quarter, stock had a quick ratio of 14.24. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 10100.70.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -3.59, a number that is poised to hit -0.99 in the next quarter and is forecasted to reach -3.93 in one year’s time.
Technical Analysis of Revolution Medicines Inc (RVMD)
Revolution Medicines Inc (NASDAQ: RVMD) saw its 5-day average volume 1.48 million, a positive change from its year-to-date volume of 1.43 million. As of the previous 9 days, the stock’s Stochastic %D was 37.46%. Additionally, its Average True Range was 1.69.
During the past 100 days, Revolution Medicines Inc’s (RVMD) raw stochastic average was set at 7.07%, which indicates a significant decrease from 27.70% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 39.81% in the past 14 days, which was lower than the 43.73% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $47.84, while its 200-day Moving Average is $44.06. Nevertheless, the first resistance level for the watch stands at $42.01 in the near term. At $43.03, the stock is likely to face the second major resistance level. The third major resistance level sits at $44.01. If the price goes on to break the first support level at $40.02, it is likely to go to the next support level at $39.04. The third support level lies at $38.02 if the price breaches the second support level.
Revolution Medicines Inc (NASDAQ: RVMD) Key Stats
The company with the Market Capitalisation of 7.47 billion has total of 168,219K Shares Outstanding. Its annual sales at the moment are 11,580 K in contrast with the sum of -436,370 K annual income. Company’s last quarter sales were recorded 0 K and last quarter income was -156,290 K.
